Warning: The NCBI web site requires JavaScript to function. more...
Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?
Machold KP, Nell VP, Stamm TA, Smolen JS.
Arthritis Res Ther. 2006;8(3):211. Epub 2006 May 15. Review.
Related citations
[Early rheumatoid arthritis].
Atzeni F, Sarzi-Puttini P.
Reumatismo. 2007 Apr-Jun;59(2):100-17. Review. Italian.
Pursuit of optimal outcomes in rheumatoid arthritis.
Scott DL.
Pharmacoeconomics. 2004;22(2 Suppl 1):13-26. Review.
Assessment and management of rheumatoid arthritis.
Haraoui B.
J Rheumatol Suppl. 2009 Jun;82:2-10. Review. Erratum in: J Rheumatol. 2009 Aug;36(8):1851.
The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T; FIN-RACo Trial Group.
Arthritis Rheum. 2009 May;60(5):1222-31.
Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.
Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.
Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.
Early rheumatoid arthritis -- is there a window of opportunity?
Cush JJ.
J Rheumatol Suppl. 2007 Nov;80:1-7. Review.
Management of early rheumatoid arthritis.
Suresh E.
J Assoc Physicians India. 2007 May;55:355-62. Review.
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
Cohen SB, Cohen MD, Cush JJ, Fleischmann RM, Mease PJ, Schiff MH, Simon LS, Weaver AL.
J Rheumatol Suppl. 2008 Feb;81:4-30; quiz 31-4. Review.
Drug management of early rheumatoid arthritis - 2008.
Sokka T, Mäkinen H.
Best Pract Res Clin Rheumatol. 2009 Feb;23(1):93-102. Review.
The efficacy of disease modifying anti-rheumatic drugs in rheumatoid arthritis in local patients of Karachi.
Baig MS, Humail SM, Zaidi SI, Noor S, Bano S, Rehman S, Fawwad A.
Pak J Biol Sci. 2009 Feb 15;12(4):339-45.
Aspects of early arthritis. Biological therapy in early arthritis--overtreatment or the way to go?
Ikeda K, Cox S, Emery P.
Arthritis Res Ther. 2007;9(3):211. Review.
Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial.
Claessen SJ, Hazes JM, Huisman MA, van Zeben D, Luime JJ, Weel AE.
BMC Musculoskelet Disord. 2009 Jun 18;10:71.
Treatment of early rheumatoid arthritis.
Geletka R, St Clair EW.
Best Pract Res Clin Rheumatol. 2003 Oct;17(5):791-809. Review.
Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H, Kavanaugh A.
Curr Opin Rheumatol. 2008 May;20(3):314-9. Review.
Innovative treatment strategies for patients with rheumatoid arthritis.
van der Kooij SM, Allaart CF, Dijkmans BA, Breedveld FC.
Curr Opin Rheumatol. 2008 May;20(3):287-94. Review.
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.
Unmet needs in rheumatoid arthritis.
Bykerk V.
J Rheumatol Suppl. 2009 Jun;82:42-6. Review.
Combination treatment strategies in early rheumatoid arthritis.
Suresh E, Lambert CM.
Ann Rheum Dis. 2005 Sep;64(9):1252-6. Epub 2005 Apr 28. Review.
Assessing adequate treatment response in patients with rheumatoid arthritis.
Bergman MJ.
Clin Ther. 2009 Jun;31(6):1219-31. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on